Andrzej Rostek/iStock via Getty Images
AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) are closing in on a pricing deal with England’s health spending watchdog to offer their breast cancer therapy. Enhertu, across the country’s National Health Service, Bloomberg News reported on Wednesday.
The National Institute for